Effect of PG102, a Water-soluble Extract from Actinidia aguta on Canine Atopic Dermatitis

개의 아토피성 피부염에 대한 다래(Actinidia aguta) 열매의 열수 추출물, PG 102의 치료효과

  • Ho, Seong-Hyun (Department of Biological Sciences, Seoul National University) ;
  • Park, Eun-Jin (Helixir, Co. Ltd., Biotechnology Incubating Center) ;
  • Choi, Jae-Hyek (College of Veterinary Surgery, Konkuk University) ;
  • Eo, Hae-Kwan (Helixir, Co. Ltd., Biotechnology Incubating Center) ;
  • Hong, Eun-Sil (Helixir, Co. Ltd., Biotechnology Incubating Center) ;
  • Kim, Sun-Young (Department of Biological Sciences, Seoul National University) ;
  • Kim, Seon-Hee (Helixir, Co. Ltd., Biotechnology Incubating Center)
  • Published : 2009.03.31

Abstract

Atopic dermatitis, caused by immune hyper-responsiveness, is wide spread in humans as well as in the dogs, especially in industrialized condition. Pet dogs are generally exposed to the same environment as their owners, and a significant portion of these animals are also known to suffer from this allergic disease. However, diagnosis and treatment methods of atopic dermatitis in animals have not been well established. We explored the possibility of using recently developed PG102 for the treatment of atopic dermatitis in the canine population. PG102 is a water soluble extract prepared from Actinidia arguta, and has been shown to produce significant therapeutic effect in variable allergy animal models. After oral administration of PG102 at a dose of 12.5 mg/kg daily for 4 weeks, severity of disease was greatly improved. IgE is one of representative members used to diagnose allergic diseases in humans. However, it is not well established whether there is any correlation between the serum level of IgE and atopic dermatitis. Our data indicated that dogs diagnosed to have atopic dermatitis contained higher level of serum IgE than the normal dogs and that treatment of dogs with PG102 significantly lowered the serum level of IgE. Taken together, this study demonstrated that PG102 treatment yielded significant amelioration of canine atopic dermatitis and down-regulation of serum IgE and that the serum level of IgE can be used as a convenient member for diagnosis of atopic dermatitis in dogs.

Keywords

References

  1. Scott, D. W., Miller, W. H. and Griffin, C. E. (2001) Small animal dermatology. 6th ed. 574-601,W.B Saunders, Philadelphia
  2. Lund, E. M., Armstrong, P.J., Kirk, C.A., Kolar, L.M. and Klausner, J.S. (1999) Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc. 214(9): 1336-41
  3. Colombo, S., Hill, P.B. and Thoday, K. L. (2007) Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy. Vet Rec. 160(25): 861-4
  4. Holden,. C. A. and Parish, W. E. (1998) Atopic dermatitis. In Champion, RH., Burton, JL., Burns DA., Breathnach, SM., Rook, A., Wilkinson, D., Edling, FJ. (Ed.), Textbook of Dermatology. 681-695, Blackwell, Oxford
  5. Leung, D. Y. and Bieber, T. (2003) Atopic dermatitis. Lancet. 361(9352): 151-60 https://doi.org/10.1016/S0140-6736(03)12193-9
  6. Tan Mei Lian, Richard, E. W. and Halliwell. (1998) Allegenspecific IgE and IgG antibodies in atopic and normal dogs. Vet immunol immunopathol. 66(3-4): 203-223 https://doi.org/10.1016/S0165-2427(98)00199-8
  7. DeBoer, D. J. and Hillier, A. (2001) The ACVD task force on canine atopic dermatitis (XVI): laboratory evaluation of dogs with atopic dermatitis with serum-based 'allergy' tests. Vet Immunol Immunopathol. 81(3-4): 277-87 https://doi.org/10.1016/S0165-2427(01)00304-X
  8. Fraser, M. A., McNeil, P. E. and Gettinby, G. (2003) Studies of serum total immunoglobulin E concentrations in atopic and non-atopic dogs. Vet Rec. 152(6): 159-63
  9. Ownby, D. R. (1998) Clinical significance of immunoglobuline E. In Middletone Jr., E. (Ed.), Allergy: Principles and Practice. 770-782, Mosby St. Louis
  10. Homburger, H. A. (1998) Method in laboratory immunology. In Middletone Jr., E. (Ed.), Allergy. 417-429, Principles and Practice, Mosby St Louis
  11. Kjellman, N. I. and Croner, S. (1984) Cord blood IgE determination for allergy prediction--a follow-up to seven years of age in 1,651 children. Ann Allergy. 53(2): 167-71
  12. Rhodes, H. L., Sporik, R., Thomas, P., Holgate, S. T., and Cogswell, J. J. (2001) Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol. 108(5): 720-5 https://doi.org/10.1067/mai.2001.119151
  13. Rothenberg, M. E. (1998) Eosinophilia. N Engl J Med. 338(22): 1592-600 https://doi.org/10.1056/NEJM199805283382206
  14. Maggi, E. (1998) The TH1/TH2 paradigm in allergy. Immunotechnology. 3(4): 233-44 https://doi.org/10.1016/S1380-2933(97)10005-7
  15. Park. E. J., Kim, B., Eo, H., Park, K., Kim, Y. and Lee, H. J., et al. (2005) Control of IgE and selective T(H)1 and T(H)2 cytokines by PG102 isolated from Actinidia arguta. J Allergy Clin Immunol. 116(5): 1151-7 https://doi.org/10.1016/j.jaci.2005.07.024
  16. Park, E. J., Park, K. C., Eo, H., Seo, J., Son, M. and Kim, K. H., et al. (2007) Suppression of spontaneous dermatitis in NC/Nga murine model by PG102 isolated from Actinidia arguta. J Invest Dermatol. 127(5): 1154-60 https://doi.org/10.1038/sj.jid.5700658
  17. AOAC. (2000) Official methods of analysis. 17th ed. 986.13, AOAC International
  18. Kim, D. and Kim, S. H., et al. (2009) Anti-allergic effects of PG102, a water-soluble extract prepared from Actinidia arguta, in a murine ovalbumin-induced asthma model. Clin Exp Allergy. 39(2): 280-9 https://doi.org/10.1111/j.1365-2222.2008.03124.x
  19. Kim, D. H., Kim, S. H. and Park, E. J., et al. (2009) Suppression of allergic diarrhea in murine OVA-induced food allergy model by PG102, prepared from Actinidia arguta. In press
  20. Hong, E. S., Kim, M. S. and Kwon, E. J., et al. (2008) Subacute toxicological study of PG102, a water-soluble extract derived from Actinidia arguta, in SD rats. Korean J Vet Res. 48(4): 413-421